Jorge Rosenthal1, Jessica Casas2, Douglas Taren2, Clinton J Alverson1, Alina Flores1, Jaime Frias3. 1. 1 National Center of Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, MS-86, Atlanta, GA 30333, USA. 2. 2 Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA. 3. 3 Carter Consulting, Atlanta, GA, USA.
Abstract
OBJECTIVE: Data on the prevalence of birth defects and neural tube defects (NTD) in Latin America are limited. The present review summarizes NTD prevalence and time trends in Latin American countries and compares pre- and post-fortification periods to assess the impact of folic acid fortification in these countries. DESIGN: We carried out a literature review of studies and institutional reports published between 1990 and 2010 that contained information on NTD prevalence in Latin America. RESULTS: NTD prevalence in Latin American countries varied from 0·2 to 9·6 per 1000 live births and was influenced by methods of ascertainment. Time trends from Bogota, Costa Rica, Dominican Republic, Guatemala City, Mexico and Puerto Rico showed average annual declines of 2·5 % to 21·8 %. Pre- and post-fortification comparisons were available for Argentina, Brazil, Chile, Costa Rica, Puerto Rico and Mexico. The aggregate percentage decline in NTD prevalence ranged from 33 % to 59 %. CONCLUSIONS: The present publication is the first to review data on time trends and the impact of folic acid fortification on NTD prevalence in Latin America. Reported NTD prevalence varied markedly by geographic region and in some areas of Latin America was among the lowest in the world, while in other areas it was among the highest. For countries with available information, time trends showed significant declines in NTD prevalence and these declines were greater in countries where folic acid fortification of staples reached the majority of the population at risk, such as Chile and Costa Rica.
OBJECTIVE: Data on the prevalence of birth defects and neural tube defects (NTD) in Latin America are limited. The present review summarizes NTD prevalence and time trends in Latin American countries and compares pre- and post-fortification periods to assess the impact of folic acid fortification in these countries. DESIGN: We carried out a literature review of studies and institutional reports published between 1990 and 2010 that contained information on NTD prevalence in Latin America. RESULTS: NTD prevalence in Latin American countries varied from 0·2 to 9·6 per 1000 live births and was influenced by methods of ascertainment. Time trends from Bogota, Costa Rica, Dominican Republic, Guatemala City, Mexico and Puerto Rico showed average annual declines of 2·5 % to 21·8 %. Pre- and post-fortification comparisons were available for Argentina, Brazil, Chile, Costa Rica, Puerto Rico and Mexico. The aggregate percentage decline in NTD prevalence ranged from 33 % to 59 %. CONCLUSIONS: The present publication is the first to review data on time trends and the impact of folic acid fortification on NTD prevalence in Latin America. Reported NTD prevalence varied markedly by geographic region and in some areas of Latin America was among the lowest in the world, while in other areas it was among the highest. For countries with available information, time trends showed significant declines in NTD prevalence and these declines were greater in countries where folic acid fortification of staples reached the majority of the population at risk, such as Chile and Costa Rica.
Authors: R J Berry; Z Li; J D Erickson; S Li; C A Moore; H Wang; J Mulinare; P Zhao; L Y Wong; J Gindler; S X Hong; A Correa Journal: N Engl J Med Date: 1999-11-11 Impact factor: 91.245
Authors: Eduardo E Castilla; Iêda M Orioli; Jorge S Lopez-Camelo; Maria da Graça Dutra; Julio Nazer-Herrera Journal: Am J Med Genet A Date: 2003-12-01 Impact factor: 2.802
Authors: Marcos J B Aguiar; Angela S Campos; Regina A L P Aguiar; Ana Maria A Lana; Renata L Magalhães; Luciana T Babeto Journal: J Pediatr (Rio J) Date: 2003 Mar-Apr Impact factor: 2.197
Authors: Joel G Ray; Chris Meier; Marian J Vermeulen; Sheila Boss; Philip R Wyatt; David E C Cole Journal: Lancet Date: 2002 Dec 21-28 Impact factor: 79.321
Authors: Anne M Molloy; Caitriona Nic Einri; Divyanshu Jain; Eamon Laird; Ruzong Fan; Yifan Wang; John M Scott; Barry Shane; Lawrence C Brody; Peadar N Kirke; James L Mills Journal: Birth Defects Res A Clin Mol Teratol Date: 2014-02-18
Authors: Dagoberto Estevez-Ordonez; Michael C Dewan; Michael J Feldman; Eleazar E Montalvan-Sanchez; Daniela M Montalvan-Sanchez; Aida A Rodriguez-Murillo; Samuel A Urrutia-Argueta; Charlotte B Cherry; Douglas R Morgan; Roberto Alvarez-Rodriguez; Christopher M Bonfield Journal: World Neurosurg Date: 2017-07-29 Impact factor: 2.104